Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection

Control of viral replication and absence of persistent HIV-1- specific immune responses

Katherine Luzuriaga, Margaret McManus, Michelle Catalina, Shane Mayack, Mark E Sharkey, Mario Stevenson, John L. Sullivan, Hannah Gay, Peter Vink, Savita G Pahwa, Saroj Bakshi, William Borkowsky, Colcen Cunningham, Stephen Pelton, Stephen Spector, Lynne Mofenson, Betsy Smith

Research output: Contribution to journalArticle

157 Citations (Scopus)

Abstract

Studies of potent antiretroviral combination regimens were undertaken in young infants to evaluate the potential for long-term suppression of viral replication and to evaluate the immune consequences of such therapies. Early combination antiretroviral therapy led to a loss of plasma viremia, cultivable virus, and labile extrachromosomal replication intermediates. Despite preservation of immune function, persistent human immunodeficiency type 1 (HIV-1)-specific immune responses were not detected in most infants. The absence of detectable, persisting immune responses in most HIV-1-infected infants treated early contrasts with what is typically seen in adults who are treated early. These results are consistent with the notion that early combination antiretroviral therapy of HIV-1-infected infants allows the long- term suppression of viral replication.

Original languageEnglish
Pages (from-to)6984-6991
Number of pages8
JournalJournal of Virology
Volume74
Issue number15
DOIs
StatePublished - Aug 1 2000
Externally publishedYes

Fingerprint

Virus Diseases
Infection Control
virus replication
Secondary Prevention
Human immunodeficiency virus 1
HIV-1
disease control
immune response
therapeutics
viremia
immunosuppression
Viremia
viruses
Therapeutics
Viruses

ASJC Scopus subject areas

  • Immunology

Cite this

Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection : Control of viral replication and absence of persistent HIV-1- specific immune responses. / Luzuriaga, Katherine; McManus, Margaret; Catalina, Michelle; Mayack, Shane; Sharkey, Mark E; Stevenson, Mario; Sullivan, John L.; Gay, Hannah; Vink, Peter; Pahwa, Savita G; Bakshi, Saroj; Borkowsky, William; Cunningham, Colcen; Pelton, Stephen; Spector, Stephen; Mofenson, Lynne; Smith, Betsy.

In: Journal of Virology, Vol. 74, No. 15, 01.08.2000, p. 6984-6991.

Research output: Contribution to journalArticle

Luzuriaga, K, McManus, M, Catalina, M, Mayack, S, Sharkey, ME, Stevenson, M, Sullivan, JL, Gay, H, Vink, P, Pahwa, SG, Bakshi, S, Borkowsky, W, Cunningham, C, Pelton, S, Spector, S, Mofenson, L & Smith, B 2000, 'Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: Control of viral replication and absence of persistent HIV-1- specific immune responses', Journal of Virology, vol. 74, no. 15, pp. 6984-6991. https://doi.org/10.1128/JVI.74.15.6984-6991.2000
Luzuriaga, Katherine ; McManus, Margaret ; Catalina, Michelle ; Mayack, Shane ; Sharkey, Mark E ; Stevenson, Mario ; Sullivan, John L. ; Gay, Hannah ; Vink, Peter ; Pahwa, Savita G ; Bakshi, Saroj ; Borkowsky, William ; Cunningham, Colcen ; Pelton, Stephen ; Spector, Stephen ; Mofenson, Lynne ; Smith, Betsy. / Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection : Control of viral replication and absence of persistent HIV-1- specific immune responses. In: Journal of Virology. 2000 ; Vol. 74, No. 15. pp. 6984-6991.
@article{523c2b418f354309a947e07fefc5c0f0,
title = "Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: Control of viral replication and absence of persistent HIV-1- specific immune responses",
abstract = "Studies of potent antiretroviral combination regimens were undertaken in young infants to evaluate the potential for long-term suppression of viral replication and to evaluate the immune consequences of such therapies. Early combination antiretroviral therapy led to a loss of plasma viremia, cultivable virus, and labile extrachromosomal replication intermediates. Despite preservation of immune function, persistent human immunodeficiency type 1 (HIV-1)-specific immune responses were not detected in most infants. The absence of detectable, persisting immune responses in most HIV-1-infected infants treated early contrasts with what is typically seen in adults who are treated early. These results are consistent with the notion that early combination antiretroviral therapy of HIV-1-infected infants allows the long- term suppression of viral replication.",
author = "Katherine Luzuriaga and Margaret McManus and Michelle Catalina and Shane Mayack and Sharkey, {Mark E} and Mario Stevenson and Sullivan, {John L.} and Hannah Gay and Peter Vink and Pahwa, {Savita G} and Saroj Bakshi and William Borkowsky and Colcen Cunningham and Stephen Pelton and Stephen Spector and Lynne Mofenson and Betsy Smith",
year = "2000",
month = "8",
day = "1",
doi = "10.1128/JVI.74.15.6984-6991.2000",
language = "English",
volume = "74",
pages = "6984--6991",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "15",

}

TY - JOUR

T1 - Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection

T2 - Control of viral replication and absence of persistent HIV-1- specific immune responses

AU - Luzuriaga, Katherine

AU - McManus, Margaret

AU - Catalina, Michelle

AU - Mayack, Shane

AU - Sharkey, Mark E

AU - Stevenson, Mario

AU - Sullivan, John L.

AU - Gay, Hannah

AU - Vink, Peter

AU - Pahwa, Savita G

AU - Bakshi, Saroj

AU - Borkowsky, William

AU - Cunningham, Colcen

AU - Pelton, Stephen

AU - Spector, Stephen

AU - Mofenson, Lynne

AU - Smith, Betsy

PY - 2000/8/1

Y1 - 2000/8/1

N2 - Studies of potent antiretroviral combination regimens were undertaken in young infants to evaluate the potential for long-term suppression of viral replication and to evaluate the immune consequences of such therapies. Early combination antiretroviral therapy led to a loss of plasma viremia, cultivable virus, and labile extrachromosomal replication intermediates. Despite preservation of immune function, persistent human immunodeficiency type 1 (HIV-1)-specific immune responses were not detected in most infants. The absence of detectable, persisting immune responses in most HIV-1-infected infants treated early contrasts with what is typically seen in adults who are treated early. These results are consistent with the notion that early combination antiretroviral therapy of HIV-1-infected infants allows the long- term suppression of viral replication.

AB - Studies of potent antiretroviral combination regimens were undertaken in young infants to evaluate the potential for long-term suppression of viral replication and to evaluate the immune consequences of such therapies. Early combination antiretroviral therapy led to a loss of plasma viremia, cultivable virus, and labile extrachromosomal replication intermediates. Despite preservation of immune function, persistent human immunodeficiency type 1 (HIV-1)-specific immune responses were not detected in most infants. The absence of detectable, persisting immune responses in most HIV-1-infected infants treated early contrasts with what is typically seen in adults who are treated early. These results are consistent with the notion that early combination antiretroviral therapy of HIV-1-infected infants allows the long- term suppression of viral replication.

UR - http://www.scopus.com/inward/record.url?scp=17544371675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17544371675&partnerID=8YFLogxK

U2 - 10.1128/JVI.74.15.6984-6991.2000

DO - 10.1128/JVI.74.15.6984-6991.2000

M3 - Article

VL - 74

SP - 6984

EP - 6991

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 15

ER -